Ability of B-Type Natriuretic Peptide Testing to Predict Cardioembolic Stroke in the General Population 　- Comparisons With C-Reactive Protein and Urinary Albumin.

CONCLUSIONS: In the general population, plasma BNP was an excellent biomarker for predicting the incidence of cardioembolic stroke when used alone or in combination with established stroke risk factors. PMID: 29386475 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29386475?dopt=Abstract

Source: Circulation Journal - January 30, 2018 Category: Cardiology Authors: Nakamura M, Ishibashi Y, Tanaka F, Omama S, Onoda T, Takahashi T, Takahashi S, Tanno K, Ohsawa M, Sakata K, Koshiyama M, Ogasawara K, Okayama A, Iwate-KENCO Study Group Tags: Circ J Source Type: research

Ability of B-Type Natriuretic Peptide Testing to Predict Cardioembolic Stroke in the General Population - Comparisons With C-Reactive Protein and Urinary Albumin.

Ability of B-Type Natriuretic Peptide Testing to Predict Cardioembolic Stroke in the General Population 　- Comparisons With C-Reactive Protein and Urinary Albumin.